Implementation of documented and written informed consent for clinical trials of communicable diseases: Lessons learned barriers solutions future directions identified during the conduct of a COVID-19 clinical trial

摘要

The communicable nature of many infectious diseases, including SARS-CoV-2, creates challenges for implementing and obtaining regulatory-compliant written informed consent. The goal of this project was to identify and evaluate processes that address these barriers while maintaining clinical and research staff safety.